Indications and Purposes
| 1 Indications And Usage Erleada Is Indicated For The Treatment Of Patients With Metastatic Castration-Sensitive Prostate Cancer (Mcspc) Non-Metastatic Castration-Resistant Prostate Cancer (Nmcrpc) Erleada Is An Androgen Receptor Inhibitor Indicated For The Treatment Of Patients With Metastatic Castration-Sensitive Prostate Cancer. ( 1 ) Non-Metastatic Castration-Resistant Prostate Cancer. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Apalutamide |